login
login

Europe Daily Bulletin No. 8170

14 March 2002
Contents Publication in full By article 42 / 51
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

America's PHARMACIA is to sell its 45% stake in the Swedish biotechnology company AMERSHAM BIOSCIENCES to its British partner AMERSHAM, for 1 bn dollars. AMERSHAM now holds all the capital in the company that had a turnover in 2001 of $860 million, with 4,500 employees.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
SUPPLEMENT